xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.authorArtikkelit"Nousiainen, Tapio"

Viitteet 1-3 / 3

Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison

Penttilä, Karri; Kuittinen, Taru; Valtola, Jaakko; Varmavuo, Ville; Ropponen, Antti; Nihtinen, Anne; Partanen, Anu; Vasala, Kaija; Lehtonen, Päivi; Pyörälä, Marja; Silvennoinen, Raija; Nousiainen, Tapio; Pelkonen, Jukka; Mäntymaa, Pentti; Jantunen, Esa
Transfusion : 10 (American Association Of Blood Banks, 2015)
Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients

Partanen, Anu; Valtola, Jaakko; Ropponen, Antti; Kuitunen, Hanne; Kuittinen, Outi; Vasala, Kaija; Ågren, L.; Penttilä, Karri; Keskinen, Leena; Pyörälä, Marja; Nousiainen, Tapio; Selander, Tuomas A.; Mäntymaa, Pentti; Pelkonen, Jukka L.T.; Varmavuo, Ville; Jantunen, Esa J.
Transfusion (19.11.2018)
Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly

Partanen, Anu; Valtola, Jaakko; Ropponen, Antti; Vasala, Kaija; Penttilä, Karri; Pyörälä, Marja; Nousiainen, Tapio; Selander, Tuomas A.; Mäntymaa, Pentti; Pelkonen, Jukka; Varmavuo, Ville; Jantunen, Esa J.
Annals of Hematology : 11 (Springer - Verlag, 01.11.2017)

Filgrastim is usually combined with chemotherapy to mobilize hematopoietic progenitor cells in non-Hodgkin lymphoma (NHL) patients. Limited information is available on the efficacy of a preemptive plerixafor (PLER) injection ...

Artikkelit - Selaus tekijän mukaan "Nousiainen, Tapio"

Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison ﻿

Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients ﻿

Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly ﻿

Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison

Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients

Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly